Valeo Pharma Inc VPHIF

Healthcare

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by bigreturn11on Sep 15, 2020 1:38am

397 Views

Post# 31558338

VPH Pharma near term upside 200% minimum

From CEO.ca. An advisor to VPH posted this earlier today after meeting with management. Seems like certainty for rapid drug pipeline growth.

"@RMaker Hi All - am, in Montreal and spending a lot of time with $VPH after speaking with management today they can see a re rated revenue target of not $100M but, $150M+ - so IMO, you are seeing possible BUY ratings increase significantly from $2.30 - more likely $4+ and thats minimal"

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale